Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
0.370
-0.035 (-8.62%)
At close: Apr 28, 2026, 4:00 PM EDT
0.359
-0.012 (-3.12%)
Pre-market: Apr 29, 2026, 7:00 AM EDT
Nexalin Technology Employees
Nexalin Technology had 6 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$50,275
Profits / Employee
-$1,370,364
Market Cap
7.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6 | 0 | - |
| Dec 31, 2023 | 6 | 0 | - |
| Dec 31, 2022 | 6 | -4 | -40.00% |
| Dec 31, 2021 | 10 | 6 | 150.00% |
| Dec 31, 2020 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 401 |
| Vivos Therapeutics | 262 |
| Co-Diagnostics | 115 |
| Beyond Air | 61 |
| Intelligent Bio Solutions | 55 |
| Biomerica | 54 |
| enVVeno Medical | 33 |
| Sintx Technologies | 32 |
NXL News
- 22 hours ago - Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia - GlobeNewsWire
- 6 days ago - Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment - GlobeNewsWire
- 13 days ago - Nexalin Advances FDA Alzheimer's Strategy Following Landmark Leadership Meetings in the U.S. and China - GlobeNewsWire
- 14 days ago - Join Nexalin's Exclusive Live Investor Webinar and Q&A Session on April 21 - GlobeNewsWire
- 19 days ago - Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents - GlobeNewsWire
- 2 months ago - Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market - GlobeNewsWire
- 2 months ago - Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders - GlobeNewsWire
- 2 months ago - Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer's, Mood Disorders, TBI & PTSD Care - GlobeNewsWire